<bill session="116" type="h" number="2376" updated="2019-09-30T17:15:32Z">
  <state datetime="2019-04-30">REPORTED</state>
  <status>
    <unknown datetime="2019-04-30"/>
  </status>
  <introduced datetime="2019-04-29"/>
  <titles>
    <title type="official" as="introduced">To require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.</title>
    <title type="short" as="introduced">Prescription Pricing for the People Act of 2019</title>
    <title type="short" as="introduced">Prescription Pricing for the People Act of 2019</title>
    <title type="display">Prescription Pricing for the People Act of 2019</title>
  </titles>
  <sponsor bioguide_id="C001093"/>
  <cosponsors>
    <cosponsor bioguide_id="C001068" joined="2019-05-01"/>
    <cosponsor bioguide_id="M001187" joined="2019-05-01"/>
    <cosponsor bioguide_id="N000002" joined="2019-04-29"/>
    <cosponsor bioguide_id="N000191" joined="2019-05-07"/>
    <cosponsor bioguide_id="P000607" joined="2019-09-18"/>
    <cosponsor bioguide_id="P000618" joined="2019-07-10"/>
    <cosponsor bioguide_id="R000613" joined="2019-05-07"/>
  </cosponsors>
  <actions>
    <action datetime="2019-04-29">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-04-29" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-04-29">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-04-30">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2019-04-30">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <calendar datetime="2019-04-30" state="REPORTED">
      <text>Ordered to be Reported by Voice Vote.</text>
    </calendar>
    <action datetime="2019-05-21">
      <text>Subcommittee Hearings Held.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Hearings, Referral"/>
    <committee subcommittee="" code="HSJU" name="House Judiciary" activity="Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="116" relation="unknown" number="2296"/>
    <bill type="s" session="116" relation="unknown" number="1227"/>
  </relatedbills>
  <subjects>
    <term name="Commerce"/>
    <term name="Business ethics"/>
    <term name="Business records"/>
    <term name="Competition and antitrust"/>
    <term name="Congressional oversight"/>
    <term name="Consumer affairs"/>
    <term name="Health care costs and insurance"/>
    <term name="Health information and medical records"/>
    <term name="Inflation and prices"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
  </subjects>
  <amendments/>
  <summary date="2019-04-29T04:00:00Z" status="Introduced in House">Prescription Pricing for the People Act of 2019

This bill directs the Federal Trade Commission to report to Congress on the effect of certain anticompetitive practices in the pharmaceutical supply chain.</summary>
  <committee-reports/>
</bill>
